Drug:
Reaction: ACUTE KIDNEY INJURY
20260101 - 20261231
No. 801 - 900
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 801 | 26831751 |
US |
67 | 2 |
Renal tubular necrosis, Metabolic acidosis, Acute kidney injury, Hyperkalaemia, Lactic acidosis, Drug interaction, Toxicity to various agents, Hypoglycaemia, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LISINOPRIL, ROSUVASTATIN, |
||||
| 802 | 26831944 |
JP |
7 | 1 |
Ketosis, Acute kidney injury, Diarrhoea, |
||||
EMPAGLIFLOZIN, EMPAGLIFLOZIN, BISOPROLOL FUMARATE, SPIRONOLACTONE, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, LANSOPRAZOLE, APIXABAN, AMIODARONE HYDROCHLORIDE, |
||||
| 803 | 26832105 |
US |
68 | 2 |
Crystal nephropathy, Acute kidney injury, Toxicity to various agents, Drug ineffective, Disease progression, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, DOXORUBICIN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYTARABINE, CYTARABINE, CYTARABINE, CYTARABINE, THIOTEPA, THIOTEPA, THIOTEPA, THIOTEPA, |
||||
| 804 | 26832114 |
US |
68 | 1 |
Acute kidney injury, Toxicity to various agents, Drug interaction, Hyperkalaemia, Metabolic acidosis, Renal tubular necrosis, Hypotension, Hypoglycaemia, Lactic acidosis, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TIRZEPATIDE, CLONIDINE, DAPAGLIFLOZIN, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, LOSARTAN, |
||||
| 805 | 26832144 |
EU |
2 | |
Acute kidney injury, Nausea, Diarrhoea, |
||||
FULVESTRANT, FULVESTRANT, INAVOLISIB, INAVOLISIB, INAVOLISIB, INAVOLISIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, |
||||
| 806 | 26832192 |
EU |
66 | 2 |
Thrombotic microangiopathy, Acute kidney injury, Diarrhoea, Abdominal pain, Transplant rejection, Off label use, |
||||
BASILIXIMAB, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 807 | 26832199 |
EU |
15 | 2 |
Renal tubular necrosis, Acute kidney injury, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 808 | 26832336 |
US |
57 | 1 |
Acute kidney injury, Renal tubular necrosis, Tubulointerstitial nephritis, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 809 | 26832366 |
EU |
36 | 2 |
Thrombotic microangiopathy, Haemoglobin decreased, Platelet count decreased, Blood pressure systolic increased, Blood lactate dehydrogenase increased, Acute kidney injury, Blood creatinine increased, Off label use, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, BASILIXIMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, BASILIXIMAB, |
||||
| 810 | 26832381 |
68 | 2 | |
Crystal nephropathy, Metastases to central nervous system, Mental status changes, Acute kidney injury, Toxicity to various agents, |
||||
PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, DOXORUBICIN, POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYTARABINE, THIOTEPA, |
||||
| 811 | 26832430 |
EU |
55 | 2 |
Thrombotic microangiopathy, Acute kidney injury, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, BASILIXIMAB, BASILIXIMAB, BASILIXIMAB, BASILIXIMAB, |
||||
| 812 | 26832483 |
EU |
81 | 2 |
Rhabdomyolysis, Acute kidney injury, Drug interaction, |
||||
DIPYRIDAMOLE, DIPYRIDAMOLE, SEVELAMER CARBONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 813 | 26832489 |
US |
54 | 1 |
Sarcoid-like reaction, Hypercalcaemia, Hilar lymphadenopathy, Pulmonary mass, Acute kidney injury, |
||||
ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
| 814 | 26832554 |
US |
67 | 1 |
Lactic acidosis, Acute kidney injury, Drug level increased, Drug interaction, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, LISINOPRIL, |
||||
| 815 | 26832644 |
CA |
67 | 2 |
Acute kidney injury, Bronchopulmonary aspergillosis, Hypoxia, Pancytopenia, Pneumonia, Respiratory failure, Sepsis, Shock, |
||||
RITUXIMAB-PVVR, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TOCILIZUMAB-AAZG, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALLOPURINOL, AMLODIPINE, APIXABAN, DEXLANSOPRAZOLE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, HYDROXYCHLOROQUINE, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, PEGFILGRASTIM, PROCHLORPERAZINE, |
||||
| 816 | 26832726 |
EU |
||
Acute kidney injury, Pancytopenia, |
||||
LURBINECTEDIN, LURBINECTEDIN, LURBINECTEDIN, APIXABAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ROSUVASTATIN, SPIRONOLACTONE, FUROSEMIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 817 | 26832861 |
EU |
65 | 1 |
Acute kidney injury, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, AMOXICILLIN AND CLAVULANATE POTASSIUM, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, CEFEPIME HYDROCHLORIDE, AZACITIDINE, AZACITIDINE FOR, |
||||
| 818 | 26832947 |
US |
44 | 1 |
Post transplant lymphoproliferative disorder, Haemoptysis, Acute kidney injury, Perforation, Gastritis, Haemorrhage, Off label use, |
||||
VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, CEFTRIAXONE, CEFTRIAXONE SODIUM, CEFTRIAXONE, CEFTRIAXONE SODIUM, CEFTRIAXONE, CEFTRIAXONE SODIUM, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CEFEPIME HYDROCHLORIDE, CEFEPIME, PREDNISONE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 819 | 26832959 |
EU |
54 | 2 |
Neuroleptic malignant syndrome, Drug interaction, Hyperglycaemia, Hypernatraemia, Acute kidney injury, Rhabdomyolysis, Pneumonia aspiration, |
||||
OLANZAPINE, LOXAPINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, TRIHEXYPHENIDYL HYDROCHLORIDE, DANTROLENE, |
||||
| 820 | 26833355 |
US |
72 | 1 |
Gastroenteritis cryptosporidial, Metabolic acidosis, Acute kidney injury, Renal tubular necrosis, Encephalopathy, |
||||
BUDESONIDE, NIVOLUMAB, VEDOLIZUMAB, SULFASALAZINE, IPILIMUMAB, PEMBROLIZUMAB, |
||||
| 821 | 26833399 |
EU |
54 | 2 |
Acute kidney injury, Cholestatic liver injury, Rash maculo-papular, Pyrexia, |
||||
IOMEPROL INJECTION, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ENOXAPARIN SODIUM, MORPHINE SULFATE, |
||||
| 822 | 26833464 |
EU |
52 | 2 |
Thrombotic microangiopathy, Acute kidney injury, Haemoglobin decreased, Blood pressure increased, Blood lactate dehydrogenase increased, Abdominal pain, Diarrhoea, Off label use, |
||||
BASILIXIMAB, EVEROLIMUS, EVEROLIMUS TABLETS, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 823 | 26833468 |
EU |
55 | 2 |
Thrombotic microangiopathy, Acute kidney injury, Blood pressure systolic increased, Platelet count decreased, Blood lactate dehydrogenase increased, Haemoglobin decreased, Off label use, |
||||
BASILIXIMAB, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 824 | 26833481 |
US |
29 | 2 |
Pneumonia haemophilus, Cerebral infarction, Aortic dissection, Acute kidney injury, Pericardial effusion, Aortic valve incompetence, Cardiac arrest, Hyperkalaemia, |
||||
HYDROXYCHLOROQUINE, PREDNISONE, |
||||
| 825 | 26833639 |
AU |
57 | 1 |
Acute kidney injury, Neutropenia, Product ineffective for unapproved use, |
||||
TERBINAFINE HYDROCHLORIDE, TERBINAFINE, TERBINAFINE HYDROCHLORIDE TABLET, AMPHOTERICIN B, CASPOFUNGIN ACETATE, CEFTAZIDIME, FOSCARNET SODIUM, MICAFUNGIN, MICAFUNGIN SODIUM, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, VORICONAZOLE, VORICONAZOLE INJECTION, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 826 | 26833732 |
EU |
70 | 1 |
Diarrhoea, Abdominal pain, Colitis microscopic, Acute kidney injury, |
||||
BUPROPION, CARBIDOPA AND LEVODOPA, TRAZODONE HYDROCHLORIDE, AMLODIPINE, |
||||
| 827 | 26833821 |
EU |
19 | 1 |
Bone marrow failure, Acute kidney injury, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, VINCRISTINE SULFATE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, MERCAPTOPURINE, CYTARABINE, CYTARABINE, CYTARABINE, CYTARABINE, CYTARABINE, CYTARABINE, CYTARABINE, CYTARABINE, CYTARABINE, CYTARABINE, CYTARABINE, CYTARABINE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, |
||||
| 828 | 26833843 |
EU |
80 | 2 |
Gastrointestinal disorder, Acute kidney injury, Lactic acidosis, Bicytopenia, |
||||
RIBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SPIRONOLACTONE, DENOSUMAB, SIMVASTATIN, |
||||
| 829 | 26833887 |
EU |
1 | |
Oedema, Weight increased, Electrolyte imbalance, Acute kidney injury, Headache, Chest pain, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ATOVAQUONE, ATOVAQUONE ORAL SUSPENSION, DAPAGLIFLOZIN, LOSARTAN, BISOPROLOL FUMARATE, AMLODIPINE BESYLATE, FUROSEMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PANTOPRAZOLE, NITROGLYCERIN, |
||||
| 830 | 26833948 |
US |
70 | 2 |
Acute kidney injury, Acute kidney injury, Acute kidney injury, Pneumonia aspiration, Ischaemic hepatitis, Arrhythmia, Overdose, Respiratory depression, Depressed level of consciousness, Hyperkalaemia, Unresponsive to stimuli, Unresponsive to stimuli, Respiratory failure, Encephalopathy, Acute myocardial infarction, Toxicity to various agents, Drug use disorder, Somnolence, Somnolence, Confusional state, Hypotension, Hypotension, Hypotension, Anaemia, Delirium, Fall, Illness, Cognitive disorder, Prescription drug used without a prescription, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, BUPRENORPHINE, BUPRENORPHINE, |
||||
| 831 | 26833989 |
69 | 2 | |
Acute kidney injury, Suspected off label use, |
||||
FINERENONE, |
||||
| 832 | 26834041 |
JP |
||
Hospitalisation, Acute kidney injury, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 833 | 26834232 |
EU |
63 | 2 |
Faecaloma, Large intestinal obstruction, Syncope, Colitis ischaemic, Hypoxia, Respiratory failure, Acute kidney injury, Lactic acidosis, Megacolon, Shock, Anuria, Myocardial infarction, Hepatic failure, Hypoglycaemia, Fall, Contusion, Dyspnoea, Somnolence, Hypotension, Dehydration, Subileus, Hypercalcaemia, Hypercapnia, Mesenteritis, General physical health deterioration, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, QUETIAPINE FUMARATE, QUETIAPINE, OXAZEPAM, ROSUVASTATIN, MINERAL OIL, UMECLIDINIUM, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 834 | 26845758 |
82 | 1 | |
Septic shock, Pneumonia, Acute kidney injury, Hyperkalaemia, Diabetic ketoacidosis, |
||||
LENALIDOMIDE, |
||||
| 835 | 26846312 |
1 | ||
Adenovirus infection, Thrombocytopenia, Haemolytic anaemia, Acute kidney injury, Thrombotic microangiopathy, Dialysis, Therapy interrupted, |
||||
LENALIDOMIDE, CARFILZOMIB, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MELATONIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, BORTEZOMIB, |
||||
| 836 | 26825128 |
EG |
67 | 1 |
Oxygen saturation decreased, Hypokalaemia, Hypoalbuminaemia, Thrombocytopenia, Leukopenia, Acute kidney injury, Dyspnoea, Heart rate increased, Fatigue, Pyrexia, Blood creatinine increased, Hyponatraemia, Febrile neutropenia, Dyspnoea, Blood urea increased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, VINCRISTINE SULFATE, ETOPOSIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 837 | 26825203 |
US |
35 | 1 |
Pancreatitis acute, Acute kidney injury, Azotaemia, Metabolic acidosis, Hyponatraemia, |
||||
LOSARTAN, LOSARTAN, AMLODIPINE, AMLODIPINE, |
||||
| 838 | 26825328 |
EU |
75 | 1 |
Tubulointerstitial nephritis, Acute kidney injury, Dyspnoea, Fibrin D dimer increased, Tubulointerstitial nephritis, |
||||
ALLOPURINOL, RANIBIZUMAB, FUROSEMIDE, INSULIN HUMAN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 839 | 26825362 |
US |
77 | 1 |
Toxicity to various agents, Lactic acidosis, Acute kidney injury, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, LISINOPRIL AND HYDROCHLOROTHIAZIDE, LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, GLIMEPIRIDE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, TERAZOSIN, TERAZOSIN HYDROCHLORIDE, |
||||
| 840 | 26825594 |
US |
24 | 1 |
Tubulointerstitial nephritis, Metabolic acidosis, Acute kidney injury, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 841 | 26825936 |
EU |
81 | 2 |
Rhabdomyolysis, Acute kidney injury, Drug interaction, |
||||
DIPYRIDAMOLE, DIPYRIDAMOLE, PANTOPRAZOLE, |
||||
| 842 | 26825954 |
EU |
43 | 2 |
Acute kidney injury, |
||||
LUSPATERCEPT, |
||||
| 843 | 26826228 |
EU |
53 | 1 |
Acute kidney injury, |
||||
FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, SPIRONOLACTONE, SPIRONOLACTONE, SPIRONOLACTONE, BUMETANIDE, BUMETANIDE, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, PROPOFOL, DOBUTAMINE HYDROCHLORIDE, HEPARIN SODIUM, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, MEROPENEM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BISOPROLOL FUMARATE, EPLERENONE, RIVAROXABAN, SACUBITRIL AND VALSARTAN, WARFARIN, |
||||
| 844 | 26826250 |
US |
67 | 1 |
Hyperkalaemia, Metabolic acidosis, Diabetic ketoacidosis, Acute kidney injury, Hypoglycaemia, Lactic acidosis, Drug interaction, Toxicity to various agents, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, LISINOPRIL, HYDROCHLOROTHIAZIDE, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PRASUGREL, TOCILIZUMAB, |
||||
| 845 | 26826254 |
EU |
78 | 1 |
Acute kidney injury, Purpura, |
||||
AMOXICILLIN, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 846 | 26826270 |
35 | ||
Acute kidney injury, Azotaemia, Metabolic acidosis, Hyponatraemia, Pancreatitis acute, |
||||
AMLODIPINE, AMLODIPINE, LOSARTAN, LOSARTAN, |
||||
| 847 | 26826453 |
JP |
22 | 1 |
Alcohol poisoning, Loss of consciousness, Acute kidney injury, Circulatory collapse, |
||||
| 848 | 26826456 |
CA |
73 | 2 |
Acute kidney injury, Gastrointestinal angiodysplasia, Hepatic enzyme increased, Red blood cell transfusion, Dyspnoea, Anaemia, Asthenia, |
||||
RIVAROXABAN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BISOPROLOL FUMARATE, CEFADROXIL, CELECOXIB, DULOXETINE HYDROCHLORIDE, DEXLANSOPRAZOLE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, FERROUS SULFATE, FUROSEMIDE, ALBUTEROL SULFATE, ALBUTEROL, SPIRONOLACTONE, TIOTROPIUM BROMIDE, |
||||
| 849 | 26826517 |
AU |
1 | |
Pyrexia, Acute kidney injury, Hyponatraemia, Hypocalcaemia, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, TRAMETINIB, DABRAFENIB, CALCIUM CARBONATE, SIMETHICONE, LACTULOSE, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 850 | 26826557 |
72 | ||
Gastroenteritis cryptosporidial, Metabolic acidosis, Acute kidney injury, Renal tubular necrosis, Encephalopathy, |
||||
BUDESONIDE, SULFASALAZINE, VEDOLIZUMAB, IPILIMUMAB, NIVOLUMAB, NIVOLUMAB, PEMBROLIZUMAB, |
||||
| 851 | 26826562 |
US |
2 | 2 |
Parvovirus B19 infection, Respiratory failure, Acute kidney injury, Multiple organ dysfunction syndrome, Normocytic anaemia, Post transplant lymphoproliferative disorder, Fungal infection, Bacterial infection, |
||||
PREDNISONE, TACROLIMUS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 852 | 26826577 |
US |
69 | 2 |
Acute kidney injury, Hyperkalaemia, Metabolic acidosis, Toxicity to various agents, Drug interaction, Hypoglycaemia, Lactic acidosis, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LINAGLIPTIN, GLYBURIDE, LISINOPRIL, |
||||
| 853 | 26826767 |
US |
57 | 1 |
Acute kidney injury, Tubulointerstitial nephritis, Renal tubular necrosis, Hypovolaemia, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, |
||||
| 854 | 26826900 |
EU |
61 | 2 |
Thrombotic microangiopathy, Acute kidney injury, Blood pressure increased, Platelet count decreased, Blood lactate dehydrogenase increased, Confusional state, Mental status changes, Haemoglobin decreased, Off label use, |
||||
BASILIXIMAB, EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 855 | 26826901 |
US |
68 | 2 |
Acute kidney injury, Crystal nephropathy, Chemotherapeutic drug level above therapeutic, Drug clearance decreased, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CYTARABINE, CYTARABINE, THIOTEPA, THIOTEPA, RITUXIMAB, RITUXIMAB, |
||||
| 856 | 26827030 |
CN |
60 | 1 |
Gastrointestinal haemorrhage, Myelosuppression, Dengue fever, Renal failure, Hypoalbuminaemia, Large intestine polyp, Gastrointestinal erosion, Acute kidney injury, Anaemia, Gastric ulcer, Renal impairment, |
||||
BASILIXIMAB, LEUCOVORIN CALCIUM, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, METHYLPREDNISOLONE, PREDNISONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 857 | 26827034 |
|||
Acute kidney injury, Off label use, |
||||
PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 858 | 26827172 |
EU |
67 | 1 |
Acute kidney injury, Malaise, Drug ineffective, Off label use, |
||||
CYCLOSPORINE, OMALIZUMAB, PREDNISONE, DUPILUMAB, |
||||
| 859 | 26827190 |
US |
54 | 2 |
Drug reaction with eosinophilia and systemic symptoms, Rash maculo-papular, Rash pruritic, Pyrexia, Hypotension, Tachycardia, Seizure, Lymphadenopathy, Hyponatraemia, Acute kidney injury, Blood lactic acid increased, Hypertransaminasaemia, |
||||
CARBAMAZEPINE, CARBAMAZEPINE, |
||||
| 860 | 26827312 |
EU |
78 | 1 |
Diarrhoea, Acute kidney injury, |
||||
FUROSEMIDE, IPILIMUMAB, IPILIMUMAB, NIVOLUMAB, NIVOLUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, FOLIC ACID, HYDROCHLOROTHIAZIDE, IRBESARTAN, LANSOPRAZOLE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, NICARDIPINE HYDROCHLORIDE, NICARDIPINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, MELATONIN, |
||||
| 861 | 26827379 |
US |
68 | 1 |
Lactic acidosis, Acute kidney injury, Shock, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LINAGLIPTIN, |
||||
| 862 | 26827399 |
US |
24 | 1 |
Tubulointerstitial nephritis, Metabolic acidosis, Acute kidney injury, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 863 | 26827405 |
EU |
64 | 1 |
Thrombotic microangiopathy, Acute kidney injury, Intestinal ischaemia, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, BASILIXIMAB, BASILIXIMAB, BASILIXIMAB, BASILIXIMAB, |
||||
| 864 | 26827553 |
US |
73 | 1 |
Acute kidney injury, Primary progressive multiple sclerosis, Condition aggravated, |
||||
LOSARTAN, GABAPENTIN, |
||||
| 865 | 26827566 |
US |
78 | 1 |
Acute kidney injury, |
||||
FUROSEMIDE, EMPAGLIFLOZIN, |
||||
| 866 | 26827735 |
US |
2 | 2 |
Parvovirus B19 infection, Respiratory failure, Acute kidney injury, Multiple organ dysfunction syndrome, Normocytic anaemia, Post transplant lymphoproliferative disorder, Fungal infection, Bacterial infection, |
||||
PREDNISONE, TACROLIMUS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 867 | 26827770 |
EU |
77 | 2 |
Acute kidney injury, |
||||
PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, RIFAMPIN, |
||||
| 868 | 26827792 |
EU |
62 | 2 |
Acute kidney injury, C-reactive protein increased, |
||||
PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, AMLODIPINE, RIFAXIMIN, |
||||
| 869 | 26827803 |
GB |
41 | 2 |
Seizure, Agranulocytosis, Acute kidney injury, Neutropenic sepsis, Maternal exposure during breast feeding, Malaise, Oropharyngeal pain, Pyrexia, |
||||
SULFASALAZINE, |
||||
| 870 | 26827883 |
US |
24 | 1 |
Tubulointerstitial nephritis, Acute kidney injury, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 871 | 26827927 |
28 | 1 | |
Acute kidney injury, Nausea, Vomiting, Fatigue, |
||||
| 872 | 26827977 |
CA |
83 | 2 |
Acute kidney injury, Asthenia, Blood creatinine increased, Blood pressure decreased, Calcium deficiency, Chronic kidney disease, Escherichia test positive, General physical health deterioration, Hyperthermia, Leukocytosis, Magnesium deficiency, Metabolic acidosis, Myalgia, Renal tubular necrosis, Urosepsis, |
||||
ZOLEDRONIC ACID, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METHOTREXATE, METHOTREXATE SODIUM, AMLODIPINE BESYLATE, PROPRANOLOL HYDROCHLORIDE, SULFASALAZINE, |
||||
| 873 | 26828285 |
US |
79 | |
Cardiac arrest, Respiratory failure, Acute kidney injury, Condition aggravated, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 874 | 26828287 |
US |
79 | |
Cardiac arrest, Respiratory failure, Acute kidney injury, Condition aggravated, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 875 | 26828380 |
EU |
52 | 2 |
Acute kidney injury, Vomiting, Nausea, Diarrhoea, |
||||
LEUCOVORIN CALCIUM, OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 876 | 26828819 |
US |
54 | 1 |
Plasma cell myeloma refractory, Acute kidney injury, |
||||
TALQUETAMAB, |
||||
| 877 | 26828956 |
EU |
64 | 1 |
Thrombotic microangiopathy, Acute kidney injury, Intestinal ischaemia, Haemoglobin decreased, Platelet count decreased, Blood pressure systolic increased, Blood lactate dehydrogenase increased, Off label use, |
||||
CYCLOSPORINE, CYCLOSPORINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, BASILIXIMAB, BASILIXIMAB, |
||||
| 878 | 26829106 |
EU |
49 | 1 |
Pancytopenia, Acute kidney injury, Rash maculo-papular, |
||||
PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, |
||||
| 879 | 26829120 |
EU |
87 | 2 |
Acute kidney injury, Overdose, Wrong product administered, Nervous system disorder, |
||||
VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, ACYCLOVIR, |
||||
| 880 | 26829251 |
EU |
61 | 1 |
Agranulocytosis, Acute kidney injury, Neutropenia, |
||||
GABAPENTIN, GABAPENTIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CEFTAROLINE FOSAMIL, DAPTOMYCIN, VORTIOXETINE, ZOLPIDEM TARTRATE, CICLOPIROX, LORAZEPAM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CICLOPIROX, FLUTICASONE PROPIONATE, MORPHINE SULFATE, |
||||
| 881 | 26829383 |
CH |
70 | 1 |
Anaemia, Acute kidney injury, Anaemia, |
||||
TICAGRELOR, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, TORSEMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LISINOPRIL, FOLIC ACID, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, AMLODIPINE BESYLATE, |
||||
| 882 | 26829682 |
US |
24 | 1 |
Tubulointerstitial nephritis, Acute kidney injury, Metabolic acidosis, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 883 | 26829734 |
US |
57 | 1 |
Acute kidney injury, Renal tubular necrosis, Tubulointerstitial nephritis, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ATENOLOL, AMLODIPINE, VALSARTAN, VALSARTAN ORAL, BACLOFEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ROSUVASTATIN, GABAPENTIN, |
||||
| 884 | 26843631 |
87 | 1 | |
Neutropenia, Acute kidney injury, Anaemia, Encephalopathy, Bronchiectasis, Mental impairment, Tremor, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LENALIDOMIDE, |
||||
| 885 | 26819447 |
CA |
87 | 1 |
Acute kidney injury, General physical health deterioration, Hyperkalaemia, |
||||
TELMISARTAN, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, DUTASTERIDE, EZETIMIBE, FERROUS SULFATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, PANTOPRAZOLE, LINAGLIPTIN, VITAMIN C, ERGOCALCIFEROL, |
||||
| 886 | 26819534 |
EU |
79 | 1 |
Thrombocytopenia, Haemolysis, Thrombotic microangiopathy, Acute kidney injury, |
||||
CARFILZOMIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 887 | 26819767 |
GB |
2 | |
Acute kidney injury, |
||||
DAPAGLIFLOZIN, |
||||
| 888 | 26819907 |
|||
Acute respiratory distress syndrome, Acute kidney injury, Shock, Septic shock, Septic cardiomyopathy, Multiple organ dysfunction syndrome, Cardiac dysfunction, Thrombocytopenia, Hypoperfusion, Lactic acidosis, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 889 | 26820020 |
AU |
35 | 1 |
Acute kidney injury, Infective pulmonary exacerbation of cystic fibrosis, Orthostatic hypotension, Liver function test abnormal, Proteinuria, Product ineffective for unapproved use, Treatment noncompliance, Off label use, Increased viscosity of bronchial secretion, Pseudomonas test positive, Sputum discoloured, Staphylococcus test positive, |
||||
DAPAGLIFLOZIN, DAPAGLIFLOZIN, DAPAGLIFLOZIN, DAPAGLIFLOZIN, DAPAGLIFLOZIN, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
| 890 | 26820043 |
|||
Acute kidney injury, Foetal renal impairment, Foetal exposure during pregnancy, |
||||
| 891 | 26820190 |
EU |
72 | 1 |
Erythema, Concomitant disease aggravated, Eosinophilia, Acute kidney injury, |
||||
EMPAGLIFLOZIN, |
||||
| 892 | 26820205 |
77 | 2 | |
Autoimmune myositis, Rhabdomyolysis, Acute kidney injury, Hypertransaminasaemia, |
||||
NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, RAMIPRIL, BISOPROLOL FUMARATE, ISOSORBIDE MONONITRATE, |
||||
| 893 | 26820233 |
US |
91 | 1 |
Rhabdomyolysis, Drug interaction, Acute kidney injury, Hypertransaminasaemia, |
||||
RANOLAZINE, NITROGLYCERIN, |
||||
| 894 | 26820271 |
60 | ||
Acute kidney injury, |
||||
AMLODIPINE, VALSARTAN, VALSARTAN ORAL, EMPAGLIFLOZIN, |
||||
| 895 | 26820478 |
US |
80 | 1 |
Acute kidney injury, |
||||
SPIRONOLACTONE, LOSARTAN, LOSARTAN, CARVEDILOL, |
||||
| 896 | 26820490 |
IN |
1 | |
Klebsiella sepsis, Urethral stenosis, Acute kidney injury, Hypoalbuminaemia, Pyrexia, Electrolyte imbalance, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, MYCOPHENOLIC ACID, |
||||
| 897 | 26820577 |
US |
68 | 1 |
Acute kidney injury, Shock, Lactic acidosis, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LINAGLIPTIN, |
||||
| 898 | 26820619 |
US |
35 | 1 |
Acute kidney injury, Pancreatitis acute, |
||||
LOSARTAN POTASSIUM, LOSARTAN, AMLODIPINE, |
||||
| 899 | 26820832 |
US |
||
Cyclic vomiting syndrome, Acute kidney injury, |
||||
ORAL SEMAGLUTIDE, |
||||
| 900 | 26820856 |
68 | 1 | |
Euglycaemic diabetic ketoacidosis, Acute kidney injury, Lactic acidosis, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LINAGLIPTIN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
